{"id":"https://openalex.org/W4404171407","doi":"https://doi.org/10.4049/jimmunol.212.supp.0448.4095","title":"Tumor-associated KLRG1+ Tregs drive a dominant immunosuppressive program in Non-small Cell Lung Cancer","display_name":"Tumor-associated KLRG1+ Tregs drive a dominant immunosuppressive program in Non-small Cell Lung Cancer","publication_year":2024,"publication_date":"2024-05-01","ids":{"openalex":"https://openalex.org/W4404171407","doi":"https://doi.org/10.4049/jimmunol.212.supp.0448.4095"},"language":"en","primary_location":{"id":"doi:10.4049/jimmunol.212.supp.0448.4095","doi":"https://doi.org/10.4049/jimmunol.212.supp.0448.4095","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.212.supp.0448.4095","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020775443","display_name":"Oluwaseyi Oluwatola","orcid":"https://orcid.org/0000-0002-9527-6493","observed_orcids":["https://orcid.org/0000-0002-9527-6493"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oluwaseyi Oluwatola","raw_affiliation_strings":["Moffitt Cancer Ctr","Univ. of South Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Ctr","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"Univ. of South Florida","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024605884","display_name":"Saheed Oluwasina Oseni","orcid":"https://orcid.org/0000-0003-1802-760X","observed_orcids":["https://orcid.org/0000-0003-1802-760X"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saheed Oseni","raw_affiliation_strings":["Moffitt Cancer Ctr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Ctr","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049090325","display_name":"Arup Kumar Bag","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arup Bag","raw_affiliation_strings":["Moffitt Cancer Ctr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Ctr","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026258084","display_name":"Dennis O. Adeegbe","orcid":"https://orcid.org/0000-0001-9233-3328","observed_orcids":["https://orcid.org/0000-0001-9233-3328"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis Adeegbe","raw_affiliation_strings":["Moffitt Cancer Ctr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Ctr","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006278901","display_name":"Shari Pilon\u2010Thomas","orcid":"https://orcid.org/0000-0001-7785-3034","observed_orcids":["https://orcid.org/0000-0001-7785-3034"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shari Pilon-Thomas","raw_affiliation_strings":["Moffitt Cancer Ctr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Ctr","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3710,"currency":"USD","value_usd":3710},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"212","issue":"1_Supplement","first_page":"0448_4095","last_page":"0448_4095"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.6797000169754028,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.6797000169754028,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.2524000108242035,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.029600000008940697,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/klrg1","display_name":"KLRG1","score":0.9959999918937683},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9860000014305115},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.9229999780654907},{"id":"https://openalex.org/keywords/co-inhibitory-receptors","display_name":"co-inhibitory receptors","score":0.8140000104904175},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.8119999766349792},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7919999957084656},{"id":"https://openalex.org/keywords/effector-t-cell-suppression","display_name":"effector T cell suppression","score":0.6980000138282776},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.7820000052452087}],"concepts":[{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5643071532249451},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5587697625160217},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4989480972290039},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43369126319885254},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.43180179595947266},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41524454951286316},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36804407835006714},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3054320514202118},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16841012239456177},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06827700138092041}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.4049/jimmunol.212.supp.0448.4095","doi":"https://doi.org/10.4049/jimmunol.212.supp.0448.4095","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.212.supp.0448.4095","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4319432259","https://openalex.org/W4404167401","https://openalex.org/W4313381368","https://openalex.org/W4396686002","https://openalex.org/W1261732063","https://openalex.org/W4225107752","https://openalex.org/W4285684911","https://openalex.org/W4312119708","https://openalex.org/W4416448210","https://openalex.org/W4415898764"],"abstract_inverted_index":{"Abstract":[0],"Killer":[1],"cell":[2,64,180,221],"lectin-like":[3],"receptor":[4,10],"G1":[5],"(KLRG1)":[6],"is":[7],"a":[8,92,138],"co-inhibitory":[9],"expressed":[11],"on":[12,32,124],"T":[13,22,34,70,100,179,220],"and":[14,23,45,58,76,120,157,170,182,212],"NK":[15,24],"cells.":[16,128],"While":[17],"KLRG1\u2019s":[18],"role":[19],"in":[20,53,62,79,91,97,155,158,168,171,197,223],"effector":[21,69,178],"cells":[25,35,71,101],"has":[26],"been":[27],"extensively":[28],"documented,":[29],"its":[30],"impact":[31],"regulatory":[33],"(Tregs)":[36],"remains":[37],"poorly":[38],"understood.":[39],"This":[40],"study":[41,145],"aims":[42],"to":[43,55],"characterize":[44],"compare":[46],"the":[47,80,125,185,198,206],"immunosuppressive":[48,195],"potential":[49,216],"of":[50,84,131,166,187,209],"KLRG1+":[51,104,148,192,210],"Tregs":[52,57,107,149,193,211],"contrast":[54],"KLRG1-":[56,106],"their":[59,214],"therapeutic":[60,215],"targeting":[61],"non-small":[63],"lung":[65,112],"cancer":[66],"(NSCLC).":[67],"CTV-labelled":[68],"were":[72,108,135],"cultured":[73],"with":[74,102,137],"TAMs":[75],"tumor":[77,127,175,199],"digests":[78],"presence":[81],"or":[82,105],"absence":[83],"each":[85],"Treg":[86,93],"subpopulation":[87],"for":[88,117,141,217],"5":[89],"days":[90],"suppression":[94],"assay.":[95],"For":[96],"vivo":[98,172],"studies,":[99],"either":[103],"adoptively":[109],"transferred":[110],"into":[111,205],"tumor-bearing":[113,132,188],"mice.":[114,189],"Intracellular":[115],"staining":[116],"GZB,":[118],"IFN-\u03b3":[119],"TNF-\u03b1":[121],"was":[122],"performed":[123],"processed":[126],"Lastly,":[129],"cohorts":[130],"KP":[133],"mice":[134],"treated":[136],"KLRG1-blocking":[139],"antibody":[140],"6":[142],"weeks.":[143],"Our":[144],"revealed":[146],"that":[147],"exhibit":[150],"robust":[151],"suppressive":[152],"functions":[153],"both":[154],"vitro":[156,169],"vivo,":[159],"contingent":[160],"upon":[161],"intact":[162],"KLRG1":[163,167],"signaling.":[164],"Blockade":[165],"profoundly":[173],"arrested":[174],"growth,":[176],"augmented":[177],"activity,":[181],"significantly":[183],"prolonged":[184],"survival":[186],"In":[190],"conclusion,":[191],"drives":[194],"activity":[196],"microenvironment;":[200],"this":[201],"provides":[202],"novel":[203],"insights":[204],"functional":[207],"dynamics":[208],"underscores":[213],"boosting":[218],"anti-tumor":[219],"responses":[222],"NSCLC.":[224]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2024-11-09T00:00:00"}